Tripos ChemCore in Maiden Deal with Schering | GenomeWeb

NEW YORK, Sept. 5 – Cheminformatics company Tripos has struck a deal with Schering AG to help the German drug giant integrate its compound research and inventory data and perform chemical tracking, Tripos said on Wednesday.

Under the deal, Tripos will allow Schering to use its ChemCore tracking system to become more efficient in the way it develops novel chemical entities, Tripos said.

The collaboration represents the first one of its kind for the ChemCore system, which incorporates Tripos’ MetaLayer technology, a company spokeswoman said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."